spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online September 16, 2005
Journal of Experimental Biology 208, 3739-3746 (2005)
Published by The Company of Biologists 2005
doi: 10.1242/jeb.01834
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skovgaard, N.
Right arrow Articles by Wang, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skovgaard, N.
Right arrow Articles by Wang, T.

Endothelin-1 causes systemic vasodilatation in anaesthetised turtles (Trachemys scripta) through activation of ETB-receptors

Nini Skovgaard1,*, Daniel E. Warren1,2, Donald C. Jackson2 and Tobias Wang1

1 Department of Zoophysiology, Institute of Biological Sciences, University of Aarhus, Denmark
2 Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI 02912, USA



View larger version (19K):

[in a new window]
 
Fig. 1. Original recordings from one turtle (Trachemys scripta) showing changes in the recorded variables following injection of ET-1 (120 pmol kg-1) and ETB-agonist (150 pmol kg-1). Arrows indicate the time of injection. Psys, systemic arterial pressure; LAo, left aortic blood flow; Ppul, pulmonary arterial pressure; LPA, left pulmonary blood flow.

 


View larger version (24K):

[in a new window]
 
Fig. 2. Effects of bolus intra-arterial injections of ET-1 on the maximum change in mean arterial systemic and pulmonary pressures, (A) Psys and (D) Ppul, respectively; systemic and pulmonary blood flows, (B) sys and (E) pul; systemic and pulmonary vascular conductances, (C) Gsys and (F) Gpul as a function of the amount of peptide injected. Data points show means ± S.E.M. for eight (systemic variables) and six (pulmonary variables) individual experiments. The asterisks denote a significant difference (P<0.05) from the pre-injection value.

 


View larger version (26K):

[in a new window]
 
Fig. 3. Effects of bolus intra-arterial injections of ET-1 on the maximum change in (A) total cardiac output (tot), (B) heart rate (fH), (C) total stroke volume (VStot) and (D) pul/sys as a function of the amount of peptide injected. Data points show means ± S.E.M. for seven individual experiments. The asterisks denote a significant difference (P<0.05) from the pre-injection value.

 


View larger version (25K):

[in a new window]
 
Fig. 4. Effects of bolus injections of ET-1 (120 pmol kg-1) before pharmacological manipulation and after infusion of ETB-antagonist (0.15 µmol kg-1) and tezosentan (15.4 µmol kg-1) on relative changes in haemodynamic variables. Data points show means ± S.E.M. for five individual experiments. Bars marked with different letters are significantly different from each other (P<0.05).

 





© The Company of Biologists Ltd 2005